Received Apr 9, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| HEPA | HEP A (HAVRIX) | GLAXOSMITHKLINE BIOLOGICALS | UNK | 2Y534 | — |
administered expired dose of Havrix; This non-serious case was reported by a nurse via call center representative and described the occurrence of expired vaccine used in a 23-month-old female patient who received HAV (Havrix) (batch number 2Y534, expiry date 02-MAR-2025) for prophylaxis. On 27-MAR-2025, the patient received Havrix. On 27-MAR-2025, an unknown time after receiving Havrix, the patient experienced expired vaccine used (Verbatim: administered expired dose of Havrix). The outcome of the expired vaccine used was not applicable. Additional Information: GSK receipt date: 02-APR-2025 The nurse reported that the expired dose of Havrix was administered to a patient which led to, expired vaccine used. The vaccine administration facility was the same as primary reporter.